Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments-Reference-Cited by-同舟云学术

Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments

Published:2017-04-14 Issue:1 Volume:17 Page:
ISSN:1471-2288
Container-title:BMC Medical Research Methodology
language:en
Short-container-title:BMC Med Res Methodol

Author:

Shinkins Bethany^ORCID,Yang Yaling,Abel Lucy,Fanshawe Thomas R.

Funder

NIHR School for Primary Care Research (SCPR)

NIHR Diagnostic Evidence Co-operative (DEC)

Publisher

Springer Science and Business Media LLC

Subject

Health Informatics,Epidemiology

Link

http://link.springer.com/content/pdf/10.1186/s12874-017-0331-7.pdf

Reference74 articles.

1. National Institute for Health and Clinical Excellence, Diagnostics Assessment Programme Manual. Manchester: National Institute for Health and Clinical Excellence; 2011.

2. Canadian Agency for Drugs and Technologies in Health. Available from: https://www.cadth.ca/ . Accessed 23 Mar 2017.

3. Health, A.G.D.o. Health Technology Assessment. Available from: http://www.health.gov.au/internet/hta/publishing.nsf/Content/home-1 . Accessed 23 Mar 2017.

4. Scotland, N. Scottish Medicines Consortium. Available from: https://www.scottishmedicines.org.uk/ . Accessed 23 Mar 2017.

5. Leeflang MM, et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008;149(12):889–97.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of methods for the analysis of diagnostic tests performed in sequence;Diagnostic and Prognostic Research;2024-09-03

2. Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations;Applied Health Economics and Health Policy;2024-02-05

3. Barriers, enablers, benefits, and drawbacks to point of care testing (POCT): a survey of the general practice out-of-hours (GPOOH) service in Scotland;BJGP Open;2023-12-13

4. Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges;Value in Health;2023-09

5. A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China;Clinical Drug Investigation;2023-03-21